BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4966140)

  • 1. Shigellosis in cynomolgus monkeys (Macaca irus). V. Resistance acquired by the repetition of experimental oral infection with Shigella flexneri 2A and fluctuation of serum agglutinin titer.
    Honjo S; Takasaka M; Fujiwara T; Kaneko M; Imaizumi K
    Jpn J Med Sci Biol; 1967 Aug; 20(4):341-8. PubMed ID: 4966140
    [No Abstract]   [Full Text] [Related]  

  • 2. Shigellosis in cynomolgus monkeys (Macaca irus). VII. Experimental production of dysentery with a relatively small dose of Shigella flexneri 2a in ascorbic acid deficient monkeys.
    Honjo S; Takasaka M; Fujiwara T; Imaizumi K; Ogawa H
    Jpn J Med Sci Biol; 1969 Jun; 22(3):149-62. PubMed ID: 4981384
    [No Abstract]   [Full Text] [Related]  

  • 3. Shigellosis in cynomolgus monkeys (Macaca irus). IV. Bacteriological and histopathological observations on the earlier stage of experimental infection with Shigella flexneri 2 A.
    Ogawa H; Honjo S; Takasaka M; Fujiwara T; Imaizumi K
    Jpn J Med Sci Biol; 1966 Feb; 19(1):22-32. PubMed ID: 4958740
    [No Abstract]   [Full Text] [Related]  

  • 4. SHIGELLOSIS IN CYNOMOLGUS MONKEYS (MACACA IRUS). II. EXPERIMENTAL INFECTION WITH SHIGELLA FLEXNERI 2A WITH SPECIAL REFERENCES TO CLINICAL AND BACTERIOLOGICAL FINDINGS.
    HONJO S; TAKASAKA M; FUJIWARA T; NAKAGAWA M; ANDOO K; OGAWA H; TAKAHASHI R; IMAIZUMI K
    Jpn J Med Sci Biol; 1964 Dec; 17():307-19. PubMed ID: 14279864
    [No Abstract]   [Full Text] [Related]  

  • 5. Shigellosis in cynomolgus monkeys (Macaca irua). VI. The inoculation with various doses of Shigella flexneri 2a into cecal lumen.
    Takasaka M; Honjo S; Fujiwara T; Imaizumi K; Ogawa H
    Jpn J Med Sci Biol; 1968 Aug; 21(4):275-81. PubMed ID: 4974847
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral challenge with Shigella flexneri 2a in cynomolgus monkeys having extremely high titer of serum agglutinin.
    Honjo S; Takasaka M; Imaizumi K; Ogawa H; Nakaya R
    Jpn J Med Sci Biol; 1968 Aug; 21(4):283-7. PubMed ID: 4974278
    [No Abstract]   [Full Text] [Related]  

  • 7. SHIGELLOSIS IN CYNOMOLGUS MONEKYS (MACACA IRUS). 3. HISTOPATHOLOGICAL STUDIES ON NATURAL AND EXPERIMENTAL SHIGELLOSIS.
    OGAWA H; TAKAHASHI R; HONJO S; TAKASKA M; FUJIWARA T; ANDO K; NAKAGAWA M; MUTO T; IMAIZUMI K
    Jpn J Med Sci Biol; 1964 Dec; 17():321-32. PubMed ID: 14279865
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental infection with small doses of virulent Shigella flexneri 2A in cynomolgus monkeys (Macaca irus). Clinical and bacteriological observations.
    Takasaka M; Honjo S; Fujiwara T; Imaizumi K; Ogawa H
    Jpn J Med Sci Biol; 1967 Apr; 20(2):195-8. PubMed ID: 4964232
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolation and pathogenicity of provisional serovar 1621-54 of "Shigella" from imported cynomolgus monkeys.
    Takasaka M; Kono A; Kono M; Nakamura A; Sakakibara I; Honjo S
    Jpn J Med Sci Biol; 1983 Feb; 36(1):27-37. PubMed ID: 6865099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shigellosis.
    Niyogi SK
    J Microbiol; 2005 Apr; 43(2):133-43. PubMed ID: 15880088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SHIGELLOSIS IN CYNOMOLGUS MONKEYS (MACACA IRUS). I. EPIDEMIOLOGICAL SURVEYS ON SHIGELLA INFECTION RATE.
    TAKASAKA M; HONJO S; FUJIWARA T; HAGIWARA T; OGAWA H; IMAIZUMI K
    Jpn J Med Sci Biol; 1964 Oct; 17():259-65. PubMed ID: 14235610
    [No Abstract]   [Full Text] [Related]  

  • 12. [Research on active immunity of man in bacillary dysentery. 3. Maintenance of the non-pathogenic character of the Shigella flexneri 2a TXXXII strain orally administered to volunteers].
    Istrati G; Meitert T; Ciufeco C
    Arch Roum Pathol Exp Microbiol; 1965 Sep; 24(3):677-86. PubMed ID: 5877879
    [No Abstract]   [Full Text] [Related]  

  • 13. Peripheral blood granulocytes and mononuclear cell responses in monkeys with experimental shigellosis.
    Islam LN; Ferdous A; Azim T; Qadri F; Rahman A; Islam MS; Tzipori S
    J Diarrhoeal Dis Res; 1994 Jun; 12(2):97-102. PubMed ID: 7963351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacillary dysentery in cynomolgus monkeys following the administration with Shigella flexneri 2A by the anal route.
    Takasaka M; Honjo S; Cho F; Imaizumi K; Ogawa H
    Jpn J Med Sci Biol; 1971 Dec; 24(6):379-85. PubMed ID: 5003951
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunity to experimental mouse shigellosis.
    Rauss K; Kétyi I
    Arch Immunol Ther Exp (Warsz); 1968; 16(3):491-6. PubMed ID: 5666686
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental infection with Shigella sonnei in cynomolgus monkeys (Macaca irus).
    Takasaka M; Honjo S; Imaizumi K; Ogawa H; Nakaya R
    Jpn J Med Sci Biol; 1969 Dec; 22(6):389-93. PubMed ID: 4985548
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental model of keratoconjunctival infections in the study of immunity against Shigella].
    Cefalù M; Puglisi C
    G Mal Infett Parassit; 1972 Apr; 24(4):281-9. PubMed ID: 5050309
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a.
    Shim DH; Chang SY; Park SM; Jang H; Carbis R; Czerkinsky C; Uematsu S; Akira S; Kweon MN
    Vaccine; 2007 Jun; 25(25):4828-36. PubMed ID: 17507120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysentery produced by oral administration of the colonic contents of cynomolgus monkeys infected with Shigella flexneri 2a.
    Takasaka M; Honjo S; Imaizumi K; Ogawa H
    Jpn J Med Sci Biol; 1970 Aug; 23(4):249-54. PubMed ID: 4992614
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of reactivation of shigellosis in naturally infected enrofloxacin-treated cynomolgus monkeys after exogenous immunosuppression.
    Black-Schultz L; Coatney RW; Warnick CL; Swif B
    Lab Anim Sci; 1997 Dec; 47(6):602-5. PubMed ID: 9433696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.